Nektar Therapeutics NKTR
NASDAQ NKTR
$74.19 -2.18 (-2.85%)
At close: Sep 4, 2026 · 4:00 PM EDT

Nektar Therapeutics (NKTR) Change in Inventory (2010 - 2024)

Nektar Therapeutics (NKTR) posted quarterly Change in Inventory of -$1.3 million for Q4 2024, down 21.85% year-over-year from -$1.7 million in Q1 2024, and down 960.98% quarter-over-quarter from -$123000.0 in Q3 2024.

Analysis

Nektar Therapeutics (NKTR) Change in Inventory (2010 - 2024) Analysis & Trends

Nektar Therapeutics' Change in Inventory history runs 15 years deep, the most recent figure standing at -$1.3 million for Q4 2024.

  • In Q4 2024, Change in Inventory fell 21.85% year-over-year to -$1.3 million; the TTM figure through Sep 2025 stood at -$1.3 million (down 396.2% YoY), while the FY2024 annual figure was -$497000.0, up 28.9% from the prior year.
  • Change in Inventory for Q4 2024 stood at -$1.3 million, down from -$123000.0 in the prior quarter.
  • The five-year high for Change in Inventory was $2.4 million in Q4 2020, with the low at -$2.4 million in Q3 2023.
  • The 5-year median for Change in Inventory is $389500.0 (2020), against an average of $267050.0.
  • Peak annual rise in Change in Inventory reached 570.38% in 2023, while the deepest fall reached 838.62% in 2023.
  • Nektar Therapeutics' Change in Inventory stood at $2.4 million in 2020, then sank by 80.38% to $471000.0 in 2021, then tumbled by 69.21% to $145000.0 in 2022, then slumped by 838.62% to -$1.1 million in 2023, then decreased by 21.85% to -$1.3 million in 2024.
  • Business Quant data shows NKTR's Change in Inventory at -$1.3 million in Q4 2024, -$123000.0 in Q3 2024, and -$212000.0 in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 27.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 28.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 132.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 47.15 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -280,000.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 12.97 Mn
10 Nektar Therapeutics 2.45 Bn 1.77 Bn 3.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -1.31 Mn
Sep 30, 2024 -123,000.00
Jun 30, 2024 -212,000.00
Mar 31, 2024 1.14 Mn
Dec 31, 2023 -1.07 Mn
Sep 30, 2023 -2.37 Mn
Jun 30, 2023 754,000.00
Mar 31, 2023 1.99 Mn
Dec 31, 2022 145,000.00
Sep 30, 2022 2.09 Mn
Jun 30, 2022 1.59 Mn
Mar 31, 2022 -422,000.00
Dec 31, 2021 471,000.00
Sep 30, 2021 714,000.00
Jun 30, 2021 -2.19 Mn
Mar 31, 2021 1.52 Mn
Dec 31, 2020 2.40 Mn
Sep 30, 2020 308,000.00
Jun 30, 2020 -1.74 Mn
Mar 31, 2020 1.66 Mn